US Patent 10226466 Methods of treating fibrosis
Patent 10226466 was granted and assigned to Pharmacyclics on March, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+288 characters)
Article
Patent abstract
Disclosed are methods of treating fibrosis in a patient, comprising administering to a patient in need thereof a therapeutically effective amount of an ACK inhibitor (e.g., a BTK inhibitor, such as for example an irreversible BTK inhibitor, such as for example, ibrutinib).
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Daniel Massó-Vallés0
Laura Soucek0
Toni Jauset González0
Edits on 26 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 5 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 25 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10226466 Methods of treating fibrosis
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10226466
Date of patent
March 12, 2019
Patent application number
15836482
Date Filed
December 8, 2017
Patent primary examiner
Find more entities like US Patent 10226466 Methods of treating fibrosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
